• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更新的破伤风类毒素、白喉类毒素和无细胞百日咳疫苗(Tdap)在孕妇和有或预计有密切接触 12 个月以下婴儿的人群中使用建议---免疫实践咨询委员会(ACIP),2011 年。

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.

出版信息

MMWR Morb Mortal Wkly Rep. 2011 Oct 21;60(41):1424-6.

PMID:22012116
Abstract

Compared with older children and adults, infants aged <12 months have substantially higher rates of pertussis and the largest burden of pertussis-related deaths. Since 2004, a mean of 3,055 infant pertussis cases with more than 19 deaths has been reported each year through the National Notifiable Diseases Surveillance System (CDC, unpublished data, 2011). The majority of pertussis cases, hospitalizations, and deaths occur in infants aged ≤2 months, who are too young to be vaccinated; therefore, other strategies are required for prevention of pertussis in this age group. Since 2005, the Advisory Committee on Immunization Practices (ACIP) has recommended tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) booster vaccines to unvaccinated postpartum mothers and other family members of newborn infants to protect infants from pertussis, a strategy referred to as cocooning. Over the past 5 years, cocooning programs have proven difficult to implement widely. Cocooning programs might achieve moderate vaccination coverage among postpartum mothers but have had limited success in vaccinating fathers or other family members. On June 22, 2011, ACIP made recommendations for use of Tdap in unvaccinated pregnant women and updated recommendations on cocooning and special situations. This report summarizes data considered and conclusions made by ACIP and provides guidance for implementing its recommendations.

摘要

与年龄较大的儿童和成人相比,<12 个月的婴儿百日咳发病率要高得多,百日咳相关死亡的负担也最大。自 2004 年以来,通过国家法定传染病监测系统(CDC,未公布数据,2011 年),每年平均报告 3055 例婴儿百日咳病例,超过 19 例死亡。大多数百日咳病例、住院和死亡发生在<2 个月的婴儿中,这些婴儿年龄太小不能接种疫苗;因此,需要其他策略来预防该年龄段的百日咳。自 2005 年以来,免疫实践咨询委员会(ACIP)建议对未接种疫苗的产后母亲和新生儿的其他家庭成员接种破伤风类毒素、白喉类毒素和无细胞百日咳(Tdap)加强疫苗,以保护婴儿免受百日咳的侵害,这一策略被称为“茧式保护”。在过去的 5 年中,“茧式保护”计划已被证明难以广泛实施。“茧式保护”计划可能会使产后母亲的疫苗接种率达到中等水平,但在为父亲或其他家庭成员接种疫苗方面收效甚微。2011 年 6 月 22 日,ACIP 就未接种疫苗的孕妇使用 Tdap 提出了建议,并更新了关于“茧式保护”和特殊情况的建议。本报告总结了 ACIP 审议的数据和结论,并为实施其建议提供了指导。

相似文献

1
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.更新的破伤风类毒素、白喉类毒素和无细胞百日咳疫苗(Tdap)在孕妇和有或预计有密切接触 12 个月以下婴儿的人群中使用建议---免疫实践咨询委员会(ACIP),2011 年。
MMWR Morb Mortal Wkly Rep. 2011 Oct 21;60(41):1424-6.
2
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.美国免疫实施咨询委员会关于破伤风类毒素、白喉类毒素和无细胞百日咳(Tdap)疫苗使用的更新建议,2010 年。
MMWR Morb Mortal Wkly Rep. 2011 Jan 14;60(1):13-5.
3
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.更新的破伤风类毒素、白喉类毒素和无细胞百日咳(Tdap)疫苗在 65 岁及以上成人中的使用建议 - 免疫实践咨询委员会(ACIP),2012 年。
MMWR Morb Mortal Wkly Rep. 2012 Jun 29;61(25):468-70.
4
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.预防成人破伤风、白喉和百日咳:免疫实践咨询委员会(ACIP)关于使用破伤风类毒素、吸附白喉类毒素和无细胞百日咳疫苗的建议,以及在医疗感染控制实践咨询委员会(HICPAC)支持下,ACIP关于医护人员使用破伤风类毒素、低剂量白喉类毒素和无细胞百日咳疫苗(Tdap)的建议。
MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.
5
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防:破伤风类毒素、白喉类毒素减少量及无细胞百日咳(Tdap)疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.
6
Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.孕期接种 Tdap 疫苗和产后襁褓包裹预防婴儿百日咳:决策分析。
Pediatrics. 2013 Jun;131(6):e1748-56. doi: 10.1542/peds.2012-3144. Epub 2013 May 27.
7
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.更新的孕妇破伤风类毒素、白喉类毒素和无细胞百日咳疫苗(Tdap)使用建议——免疫实践咨询委员会(ACIP),2012 年。
MMWR Morb Mortal Wkly Rep. 2013 Feb 22;62(7):131-5.
8
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).孕妇和产后妇女及其婴儿百日咳、破伤风和白喉的预防——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51.
9
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
10
Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.成人(年龄≥18 岁)破伤风和百日咳疫苗接种率-美国,1999 年和 2008 年。
MMWR Morb Mortal Wkly Rep. 2010 Oct 15;59(40):1302-6.

引用本文的文献

1
Knowledge, Attitudes, and Practices Regarding Influenza and Pertussis Immunization During Pregnancy in Greece.希腊孕期流感和百日咳免疫接种的知识、态度及实践情况
Vaccines (Basel). 2025 Mar 25;13(4):347. doi: 10.3390/vaccines13040347.
2
Vaccination During Pregnancy in the Vaccine Safety Datalink, 2002-2022.2002 - 2022年疫苗安全数据链中的孕期疫苗接种情况
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S105-S107. doi: 10.1097/INF.0000000000004607. Epub 2025 Feb 14.
3
Pertussis Vaccination for Adults: An Updated Guide for Clinicians.
成人百日咳疫苗接种:临床医生最新指南
Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060.
4
Factors associated with pregnant women's willingness to receive maternal pertussis vaccination in Guizhou Province, China: An exploratory cross-sectional study.与贵州省孕妇接受百白破疫苗接种意愿相关的因素:一项探索性横断面研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2331870. doi: 10.1080/21645515.2024.2331870. Epub 2024 Apr 4.
5
Factors Affecting the Implementation and Acceptance of the Cocoon Strategy in the NICU in a Tertiary Center in Türkiye.影响土耳其一家三级中心新生儿重症监护病房(NICU)实施和接受蚕茧策略的因素
Vaccines (Basel). 2024 Mar 18;12(3):319. doi: 10.3390/vaccines12030319.
6
Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions.为保护婴儿进行的产前母体免疫:推荐疫苗、婴儿免疫及未来研究方向综述
Pathogens. 2024 Feb 23;13(3):200. doi: 10.3390/pathogens13030200.
7
The impact of maternal pertussis vaccination recommendation on infant pertussis incidence and mortality in the USA: an interrupted time series analysis.母亲百日咳疫苗接种建议对美国婴儿百日咳发病率和死亡率的影响:一项中断时间序列分析。
Int J Epidemiol. 2024 Feb 1;53(1). doi: 10.1093/ije/dyad161.
8
Improving Tdap maternal immunization rate in Saudi Arabia.提高沙特阿拉伯 Tdap 母体免疫接种率。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2253585. doi: 10.1080/21645515.2023.2253585.
9
Maternal vaccination: shaping the neonatal response to pertussis.母体疫苗接种:塑造新生儿对百日咳的反应。
Front Immunol. 2023 Jul 12;14:1210580. doi: 10.3389/fimmu.2023.1210580. eCollection 2023.
10
Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.母体全细胞或无细胞百日咳疫苗初免对新生儿免疫应答的影响。
Front Immunol. 2023 Jun 26;14:1192119. doi: 10.3389/fimmu.2023.1192119. eCollection 2023.